期刊文献+

HU-308药物缓释涂层对骨质疏松大鼠种植体骨结合及新生骨的影响 被引量:2

The effect of HU-308 coated on titanium implants on osseointegration and new bone in osteoporotic rats
下载PDF
导出
摘要 目的:研究HU-308药物缓释涂层对骨质疏松大鼠种植体骨结合及新生骨的影响。方法:60只大鼠随机分成2组:对照组(S)15只,骨质疏松组(M)45只。再将M组大鼠随机平均分为M1、M2、M3组,每组15只。在所有大鼠双侧胫骨骭骺端植入种植钉,S、M1组植入普通钛钉,M2组植入肝素-壳聚糖涂层钛钉,M3组植入HU-308/肝素-壳聚糖涂层钛钉。于种植术后4周、8周、12周各组分别随机处死5只大鼠。所有大鼠处死前第18、19天及处死前第3、4天,每日腹腔内注射钙黄绿素15mg/kg。带种植体的胫骨制作不脱钙骨组织磨片,甲苯胺蓝染色,荧光显微镜及光镜下观测计算骨矿化沉积率(MAR)、荧光周长百分数(%L.Pm)、种植体-骨结合率(OI)。结果:4周和8周时,M3组MAR、%L.Pm均与S组无显著性差异(P>0.05),且均显著大于M1和M2组(P<0.05);12周时,S组MAR、%L.Pm均显著小于M1、M2、M3组(P<0.05),M1、M2、M3组间差异不显著(P>0.05)。4周、8周及12周时,S组OI均显著大于M3组;而M3组OI除12周时与M1、M2组无显著差异外,其他时期均显著大于M1、M2组(P<0.05)。结论:1、骨质疏松能抑制种植体周骨矿化沉积和新骨形成,使骨组织塑形改建时间延长,种植体-骨界面骨结合率下降。2、HU-308药物缓释涂层在种植体植入早中期可加快骨质疏松大鼠种植体周新骨形成和骨矿化沉积,促进种植体骨结合。 Objective: To investigate the effect of HU-308 coated on titanium implants on osseointegration and new bone in osteoporotic rats. Methods: Sixty rats were randomly divided into 2 groups: control group(S, 15 rats), osteoporosis group (M, 45 rats). The 45 rats in M were randomly divided into 3 groups: M1, M2, M3. Different titanium screws were implanted into the proximal metaphyses of all rats' bilateral tibias. 4, 8 and 12 weeks after implantation, 5 of the rats of each group were randomly sacrificed. The rats were given intraperitoneal injection of calcein 15mg/kg each time on the 19th, 18th, 4th and 3rd day before sacrificed. After sacrificed, the tibias with implants were removed to prepare undecalcified grinding slices and measured the mineral apposition rate(MAR), percent labeled perimeter(%L.Pm) and osseointegration index(OI). Results: 4 and 8 weeks after implantation, MAR and %L.Pm in group M3 were similar to those of group S(P〉0.05), and those in group M3 and S were all significantly higher than group M1 and M2(P〈0.05). 12 weeks after implantation, MAR and %L.Pm in group S were all significantly lower than those in group M1, M2 and M3(P〈0.05), and the differences among group M1, M2 and M3 were not significant(P〉0.05). 4, 8 and 12 weeks after implantation, the OI of S were all significantly higher than M3; the OI of M3 were significantly higher than M1 and M2 in 4 and 8 weeks (P 〈0.05).Conclusion: 1. Osteoporosis could inhibit bone mineralization and bone formation, prolong the bone rebuilding time, and decrease OI in implant-bone interface. 2. HU-308 coated on titanium implants could promote new bone formation and bone mineralization at the early-middle stage of implantation, improve osseointegration in implant-bone interface.
出处 《中华老年口腔医学杂志》 2014年第2期74-79,共6页 Chinese Journal of Geriatric Dentistry
基金 广西医疗卫生重点科研课题(项目编号:2010083)
关键词 HU-308 骨质疏松 种植体 骨结合 新生骨 HU-308 osteoporosis, dental implant osseointegration new bone
  • 相关文献

参考文献15

  • 1Branemark PI, Zarb G, Albrektsson T. Introduction to Osseointegration. In: Branemark PI, Zarb GA, Albrektsson T (eds).Tissue-Integrated Prostheses Osseointegration in Clinical Dentistry. Chicago = Quintessence, 1985 : 11-76.
  • 2Horst-Sikorska W, Dytleld J, Wawrzyniak A, et al. Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis[J]. Mol Biol Rep, 2013,40(1 ) 383-390.
  • 3Streckfus CF, Johnson RB, Nick T, et al. Comparison of alveolar bone loss, alveolar bone density and second metacarpal bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausaland postmenopausal women on estrogen therapy[J]. J Geron- tol A Biol Sci Med Sci. 1997,52(6) : 343-351.
  • 4Karsak M, Cohen-Solal M, Freudenberg J, et al. Cannabi- noid receptor type 2 gene is associated with human osteo- porosis [J]. Hum Mol Genet. 2005,14(22): 3389-3396.
  • 5李亚男,刘洪臣,倪紫砚,王东胜,邱华.骨质疏松状态下牙种植体骨整合改变的实验研究[J].口腔颌面修复学杂志,2000,1(1):29-31. 被引量:16
  • 6Hanus L, Breuer A, Tchilibon S, et al. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor[J]. Proc Natl Acad Sci USA , 1999,96(25) : 14228-14233.
  • 7Ofek O, Karsak M, Leclerc N, et al. Peripheral cannabinoid receptor, CB2, regulates bone mass[J]. Proc Natl Acad Sci USA, 2006,103(3) :696-701.
  • 8Lelovas PP, Xanthos TT, Thoma SE, et al. The laboratory rat as an animal model for osteoporosis research [J]. Comp Med, 2008,58(5): 424-430.
  • 9舒瑶,李全利,欧国敏,宫苹,邹敬才.壳聚糖-肝素静电自组装多层膜在钛表面进行的生物化修饰[J].中国组织工程研究与临床康复,2010,14(21):3832-3838. 被引量:9
  • 10焦洋,王俊红,赵燕,王晓敏.骨质疏松症与颌骨及种植体关系的研究进展[J].中国骨质疏松杂志,2006,12(3):301-303. 被引量:4

二级参考文献87

  • 1史凤芹,于世凤,徐莉,段云波,刘忠厚.牙周炎患者腰椎和牙槽骨骨密度测量分析[J].中华口腔医学杂志,1996,31(1):3-5. 被引量:18
  • 2焦洋,王俊红,赵燕,王晓敏.骨质疏松症与颌骨及种植体关系的研究进展[J].中国骨质疏松杂志,2006,12(3):301-303. 被引量:4
  • 3中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006.09-30
  • 4Albrektsson T,Jacobsson M.Bone-metal interface in osseointegration.J Prosthet Dent.1987:57(5):597-607.
  • 5Le Guéhennec L,Soueidan A,Layrolle P,et al.Surface treatments of titanium dental implants for rapid osseointegration.Dent Mater.2007:23(7):844-854.
  • 6Puleo DA,Nanci A.Understanding and controlling the bone-implant interface.Biomaterials.1999;20(23-24):2311-2321.
  • 7Tirrell M,Kokkoli E,Biesalski M.The role of surface science in bioengineered materials.Surface Science.2002;500(1-3):61-83.
  • 8Stanford CM.Surface modification of implants.Oral Maxillofacial Surg Clin N Am.2002;14(1):39-51.
  • 9Decher G.Fuzzy nanoassemblies:toward layered polymeric multicomposites.Science.1997:277(5330):1232-1237.
  • 10Cai K,Rechtenbach A,Hao J,et al.Polysaccharide-protein surface modification of titanium via a layer-by-layer technique:characterization and cell behaviour aspects.Biomaterials.2005;26(30):5960-5971.

共引文献30

同被引文献28

  • 1Viera-Negron Y E, Ruan W H, Winger J N, et al. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone[J]. J Oral Implantol, 2008, 34(2): 76-82.
  • 2Li Y, Li Q, Zhu S, et al. The effect of strontium-substituted hydroxyapatite coating on implant fixation in ovariec- tomized rats[J]. Biomaterials, 2010, 31(34): 9006-9014.
  • 3Ofek O, Karsak M, Leclerc N, et al. Peripheral earmabinoid receptor, CB2, regulates bone mass[J]. Proc Natl Acad Sci, 2006, 103(3): 696-701.
  • 4Nakamuta H. [The ovariectomized animal model of post- menopausal bone loss] [J]. Nihon Rinsho, 2004, 62 (02): 759-763.
  • 5Wronski T J, Walsh C C, Ignaszewski L A. Histologic evi- dence for osteopenia and increased bone turnover in ovariec- tomizedrats[J]. Bone, 1986, 7(2): 119-123.
  • 6Matluche H H, Sherman D, Meyer W, et al. A new semiau- tomatic method for quantitative static and dynamic bone histology[J]. Calcif Tissue Int, 1982, 34(5): 439-448.
  • 7Pan J, Shirota T, Ohno K, et al. Effect of ovariectomy on bone remodeling adjacent to hydroxyapatite-coated implants in the tibia of mature rats [J]. J Oral Maxillofac Surg, 2000, 58(8): 877-882.
  • 8Sakakura C E, Giro G, Goncalves D, et al. Radiographic assessment of bone density around integrated titanium im- plants after ovariectomy in rats[J]. Clin Oral Implants Res, 2006, 17(2): 134-138.
  • 9Engstrand T, Veltheim R, Arnander C, et al. A novel biodegradable delivery system for bone morphogenetic pro- tein-2[J]. Plast Reconstr Surg, 2008, 121(6): 1920-1928.
  • 10Sophocleous A, Landao-Bassonga E, Van't H R, et al. The type 2 carmabinoid receptor regulates bone mass and ovariec- tomy-induced bone loss by affecting osteoblast differentia- tion and bone formation[J]. Endocrinology, 2011, 152 (6) : 2141-2149.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部